Trichobrachin-IB
| Internal ID | 14a7d0f8-fb37-422a-b5f3-193977c02313 |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | 2-[[2-[[2-[[2-[[2-[[1-[2-[[2-[[2-[[2-[[2-[[2-[[2-[2-[[2-[2-[[2-[2-[(2-acetamido-2-methylpropanoyl)amino]propanoylamino]-2-methylpropanoyl]amino]propanoylamino]-2-methylpropanoyl]amino]propanoylamino]-5-amino-5-oxopentanoyl]amino]-2-methylpropanoyl]amino]-3-methylbutanoyl]amino]-2-methylpropanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-2-methylpropanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-2-methylpropanoyl]amino]-2-methylbutanoyl]amino]-5-amino-5-oxopentanoyl]amino]-5-amino-5-oxopentanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C82H140N22O24/c1-27-82(26,73(127)93-46(30-33-51(83)106)60(113)92-48(66(119)120)32-35-53(85)108)103-72(126)80(22,23)102-64(117)55(40(4)5)94-63(116)50-29-28-36-104(50)74(128)81(24,25)100-62(115)49(37-39(2)3)90-54(109)38-86-67(121)75(12,13)101-65(118)56(41(6)7)95-71(125)79(20,21)99-61(114)47(31-34-52(84)107)91-57(110)42(8)87-69(123)77(16,17)97-59(112)44(10)89-70(124)78(18,19)98-58(111)43(9)88-68(122)76(14,15)96-45(11)105/h39-44,46-50,55-56H,27-38H2,1-26H3,(H2,83,106)(H2,84,107)(H2,85,108)(H,86,121)(H,87,123)(H,88,122)(H,89,124)(H,90,109)(H,91,110)(H,92,113)(H,93,127)(H,94,116)(H,95,125)(H,96,105)(H,97,112)(H,98,111)(H,99,114)(H,100,115)(H,101,118)(H,102,117)(H,103,126)(H,119,120) |
| InChI Key | HERGFUOOBTVURT-UHFFFAOYSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C82H140N22O24 |
| Molecular Weight | 1818.10 g/mol |
| Exact Mass | 1817.04108342 g/mol |
| Topological Polar Surface Area (TPSA) | 711.00 Ų |
| XlogP | -3.30 |
| Atomic LogP (AlogP) | -5.68 |
| H-Bond Acceptor | 23 |
| H-Bond Donor | 22 |
| Rotatable Bonds | 51 |
| RefChem:191056 |
| 2-((1-Hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((hydroxy(1-(2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxyethylidene)amino)-2-methylpropylidene)amino)propylidene)amino)-2-methylpropylidene)amino)propylidene)amino)-2-methylpropylidene)amino)propylidene)amino)-4-(C-hydroxycarbonimidoyl)butylidene)amino)-2-methylpropylidene)amino)-3-methylbutylidene)amino)-2-methylpropylidene)amino)ethylidene)amino)-4-methylpentylidene)amino)-2-methylpropanoyl)pyrrolidin-2-yl)methylidene)amino)-3-methylbutylidene)amino)-2-methylpropylidene)amino)-2-methylbutylidene)amino)-4-(C-hydroxycarbonimidoyl)butylidene)amino)-4-(C-hydroxycarbonimidoyl)butanoate |
| 2-((2-((2-((2-((2-((1-(2-((2-((2-((2-((2-((2-((2-(2-((2-(2-((2-(2-((2-acetamido-2-methylpropanoyl)amino)propanoylamino)-2-methylpropanoyl)amino)propanoylamino)-2-methylpropanoyl)amino)propanoylamino)-5-amino-5-oxopentanoyl)amino)-2-methylpropanoyl)amino)-3-methylbutanoyl)amino)-2-methylpropanoyl)amino)acetyl)amino)-4-methylpentanoyl)amino)-2-methylpropanoyl)pyrrolidine-2-carbonyl)amino)-3-methylbutanoyl)amino)-2-methylpropanoyl)amino)-2-methylbutanoyl)amino)-5-amino-5-oxopentanoyl)amino)-5-amino-5-oxopentanoic acid |
| 2-[(1-Hydroxy-2-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxy-2-{[hydroxy(1-{2-[(1-hydroxy-2-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxy-2-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxy-2-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxy-2-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxyethylidene)amino]-2-methylpropylidene}amino)propylidene]amino}-2-methylpropylidene)amino]propylidene}amino)-2-methylpropylidene]amino}propylidene)amino]-4-(C-hydroxycarbonimidoyl)butylidene}amino)-2-methylpropylidene]amino}-3-methylbutylidene)amino]-2-methylpropylidene}amino)ethylidene]amino}-4-methylpentylidene)amino]-2-methylpropanoyl}pyrrolidin-2-yl)methylidene]amino}-3-methylbutylidene)amino]-2-methylpropylidene}amino)-2-methylbutylidene]amino}-4-(C-hydroxycarbonimidoyl)butylidene)amino]-4-(C-hydroxycarbonimidoyl)butanoate |
| 2-[[2-[[2-[[2-[[2-[[1-[2-[[2-[[2-[[2-[[2-[[2-[[2-[2-[[2-[2-[[2-[2-[(2-acetamido-2-methylpropanoyl)amino]propanoylamino]-2-methylpropanoyl]amino]propanoylamino]-2-methylpropanoyl]amino]propanoylamino]-5-amino-5-oxopentanoyl]amino]-2-methylpropanoyl]amino]-3-methylbutanoyl]amino]-2-methylpropanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-2-methylpropanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-2-methylpropanoyl]amino]-2-methylbutanoyl]amino]-5-amino-5-oxopentanoyl]amino]-5-amino-5-oxopentanoic acid |
| CHEBI:199667 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.6394 | 63.94% |
| Caco-2 | - | 0.8581 | 85.81% |
| Blood Brain Barrier | - | 0.7000 | 70.00% |
| Human oral bioavailability | - | 0.6571 | 65.71% |
| Subcellular localzation | Lysosomes | 0.6230 | 62.30% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8442 | 84.42% |
| OATP1B3 inhibitior | + | 0.9387 | 93.87% |
| MATE1 inhibitior | - | 0.9800 | 98.00% |
| OCT2 inhibitior | - | 0.9750 | 97.50% |
| BSEP inhibitior | + | 0.9433 | 94.33% |
| P-glycoprotein inhibitior | + | 0.7420 | 74.20% |
| P-glycoprotein substrate | + | 0.8447 | 84.47% |
| CYP3A4 substrate | + | 0.7298 | 72.98% |
| CYP2C9 substrate | + | 0.6058 | 60.58% |
| CYP2D6 substrate | - | 0.8683 | 86.83% |
| CYP3A4 inhibition | - | 0.7873 | 78.73% |
| CYP2C9 inhibition | - | 0.8896 | 88.96% |
| CYP2C19 inhibition | - | 0.7560 | 75.60% |
| CYP2D6 inhibition | - | 0.9197 | 91.97% |
| CYP1A2 inhibition | - | 0.9044 | 90.44% |
| CYP2C8 inhibition | + | 0.6537 | 65.37% |
| CYP inhibitory promiscuity | - | 0.9734 | 97.34% |
| UGT catelyzed | - | 0.0000 | 0.00% |
| Carcinogenicity (binary) | - | 0.8200 | 82.00% |
| Carcinogenicity (trinary) | Non-required | 0.6120 | 61.20% |
| Eye corrosion | - | 0.9843 | 98.43% |
| Eye irritation | - | 0.8955 | 89.55% |
| Skin irritation | - | 0.7959 | 79.59% |
| Skin corrosion | - | 0.9060 | 90.60% |
| Ames mutagenesis | - | 0.7078 | 70.78% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6944 | 69.44% |
| Micronuclear | + | 0.6000 | 60.00% |
| Hepatotoxicity | + | 0.6948 | 69.48% |
| skin sensitisation | - | 0.8906 | 89.06% |
| Respiratory toxicity | + | 0.7333 | 73.33% |
| Reproductive toxicity | + | 0.8111 | 81.11% |
| Mitochondrial toxicity | + | 0.6500 | 65.00% |
| Nephrotoxicity | - | 0.8147 | 81.47% |
| Acute Oral Toxicity (c) | III | 0.6433 | 64.33% |
| Estrogen receptor binding | - | 0.5300 | 53.00% |
| Androgen receptor binding | + | 0.7535 | 75.35% |
| Thyroid receptor binding | + | 0.7520 | 75.20% |
| Glucocorticoid receptor binding | + | 0.8160 | 81.60% |
| Aromatase binding | + | 0.7974 | 79.74% |
| PPAR gamma | + | 0.7983 | 79.83% |
| Honey bee toxicity | - | 0.7554 | 75.54% |
| Biodegradation | - | 0.8750 | 87.50% |
| Crustacea aquatic toxicity | - | 0.5176 | 51.76% |
| Fish aquatic toxicity | + | 0.6809 | 68.09% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.83% | 98.95% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 99.78% | 94.45% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 99.18% | 95.17% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 98.90% | 98.94% |
| CHEMBL3837 | P07711 | Cathepsin L | 98.84% | 96.61% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 98.79% | 93.56% |
| CHEMBL236 | P41143 | Delta opioid receptor | 98.53% | 99.35% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 98.38% | 98.33% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 98.31% | 98.24% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.98% | 96.09% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 96.57% | 99.77% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 96.18% | 96.47% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 96.15% | 92.38% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 95.41% | 100.00% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 95.12% | 98.10% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 95.12% | 100.00% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 95.09% | 83.14% |
| CHEMBL4801 | P29466 | Caspase-1 | 94.49% | 96.85% |
| CHEMBL1914 | P06276 | Butyrylcholinesterase | 94.35% | 95.00% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 94.23% | 91.19% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 94.14% | 95.38% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 93.90% | 100.00% |
| CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 93.69% | 87.16% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 93.40% | 96.03% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 93.31% | 93.00% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 93.29% | 97.09% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 93.01% | 96.38% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 92.50% | 97.14% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 92.05% | 96.67% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 91.40% | 93.33% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 90.94% | 91.11% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 90.88% | 92.80% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 90.42% | 96.28% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 90.37% | 98.89% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 90.13% | 97.23% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 90.11% | 89.63% |
| CHEMBL1841 | P06241 | Tyrosine-protein kinase FYN | 90.06% | 81.29% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 89.95% | 96.67% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 89.90% | 90.17% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 89.73% | 83.10% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 89.56% | 96.00% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 89.24% | 97.43% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 89.05% | 99.17% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 88.93% | 97.50% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 88.85% | 95.71% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 88.82% | 89.50% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 88.22% | 82.69% |
| CHEMBL206 | P03372 | Estrogen receptor alpha | 88.17% | 97.64% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 87.91% | 90.71% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 87.73% | 94.66% |
| CHEMBL3234 | P08631 | Tyrosine-protein kinase HCK | 87.72% | 88.89% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 87.01% | 97.50% |
| CHEMBL274 | P51681 | C-C chemokine receptor type 5 | 86.35% | 98.77% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 86.02% | 97.25% |
| CHEMBL344 | Q99705 | Melanin-concentrating hormone receptor 1 | 85.96% | 92.50% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 85.90% | 97.64% |
| CHEMBL283 | P08254 | Matrix metalloproteinase 3 | 85.83% | 97.29% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 85.67% | 90.24% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 85.66% | 94.45% |
| CHEMBL3018 | Q9Y5Y6 | Matriptase | 84.79% | 98.33% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 84.58% | 97.29% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 84.50% | 96.31% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 84.12% | 94.33% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 84.11% | 93.10% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 83.96% | 94.00% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 83.87% | 88.42% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 83.82% | 100.00% |
| CHEMBL4246 | P42680 | Tyrosine-protein kinase TEC | 83.63% | 82.05% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 83.42% | 95.00% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 83.13% | 82.38% |
| CHEMBL249 | P25103 | Neurokinin 1 receptor | 82.92% | 99.17% |
| CHEMBL4660 | P28907 | Lymphocyte differentiation antigen CD38 | 82.87% | 95.27% |
| CHEMBL5600 | P27448 | Serine/threonine-protein kinase c-TAK1 | 82.69% | 88.81% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 82.68% | 98.05% |
| CHEMBL5028 | O14672 | ADAM10 | 82.17% | 97.50% |
| CHEMBL2534 | O15530 | 3-phosphoinositide dependent protein kinase-1 | 81.99% | 95.36% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 81.92% | 95.89% |
| CHEMBL3776 | Q14790 | Caspase-8 | 81.66% | 97.06% |
| CHEMBL2664 | P23526 | Adenosylhomocysteinase | 81.31% | 86.67% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 80.66% | 96.90% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 80.58% | 96.33% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 80.53% | 92.12% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 80.20% | 95.50% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139583780 |
| LOTUS | LTS0206977 |
| wikiData | Q75067385 |